OralDNA Labs

What OralDNA Labs does

OralDNA Labs, a service of Access Genetics LLC, is a CLIA-certified clinical laboratory founded in 2008 and headquartered in Eden Prairie, Minnesota, that provides salivary diagnostic testing services to dental and medical providers in the United States. Its portfolio centers on tests that identify bacterial pathogens associated with periodontal disease (MyPerioPath, MyPerioID IL-6), assess HPV-related oral cancer risk (OraRisk HPV), and screen for caries risk, Candida, HSV, and multi-pathogen infectious disease (OraRisk Caries, OraRisk Candida, OraRisk HSV, Celsus One), all collected via a proprietary universal 30-second swish-and-gargle oral rinse kit. The company recently acquired a patent-pending real-time quantitative PCR platform from Sensible Diagnostics to extend into point-of-care rapid molecular testing.

The business operates on a sales-led, B2B model in which dental practices, dental support organizations, and research institutions order tests that are processed at the company's CLIA-certified lab, with results returned to providers for treatment planning. Distribution is anchored by a channel partnership with Pacific Dental Services (PDS), a dental support organization with 1,000+ supported practices, alongside direct sales to independent providers and a website-based provider finder. Pricing is not publicly disclosed and appears to be quote-based, ordered through providers who then bill patients or third-party payors. Marketing emphasizes clinical evidence, case studies, and educational content targeted at dental professionals, with no disclosed venture funding, no public listing, and no independently disclosed revenue figures.

Name

OralDNA Labs

Legal name

OralDNA Labs, A Service of Access Genetics LLC

Website

https://oraldna.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

11–50 employees

Short description

OralDNA Labs is a CLIA-certified clinical laboratory providing salivary diagnostic tests for dental providers, including periodontal pathogen detection (MyPerioPath), HPV-related oral cancer risk (OraRisk HPV), and caries and infectious disease screening, distributed via direct sales and partnerships with dental support organizations.

Ownership category

akta.pro rank

Product category

Salivary Diagnostics Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)

SIC

Services-Medical Laboratories (8071), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

akta.pro secondary industries

Oral Cancer Screening (HLABAHAF), Molecular & Genetic Testing (PCR/NGS/qPCR) (HLAGADAF), Periodontal Diagnostics & Risk Assessment (Perio Charting/Microbial Testing) (HLABACAL)

Keywords

• Salivary diagnostics
• Periodontal testing
• Oral HPV screening
• Lab testing services
• Oral health diagnostics

Headquarters

HQ city

Eden Prairie

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain

Revenue model

1. Laboratory Diagnostic Testing Services: OralDNA Labs generates revenue through providing salivary diagnostic testing services to dental providers. Dental practices collect patient samples using the oral rinse kit and send them to the lab for analysis. Results are returned to providers for use in treatment planning.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

OralDNA Labs is a CLIA-certified specialty laboratory that provides salivary diagnostic testing services to dental and medical providers. The company offers a portfolio of tests that identify bacterial pathogens, genetic markers, and viruses from a single 30-second oral rinse sample, enabling dentists to detect periodontal disease, assess caries risk, screen for HPV-related oral cancers, and evaluate fungal and viral infections. Samples are collected by dental providers using a universal oral rinse kit, sent to the OralDNA lab for molecular analysis, and results are returned to the ordering clinician for use in evidence-based treatment planning.

Product overview

OralDNA Labs provides a portfolio of salivary diagnostic tests designed for dental and medical practices. The core offering centers on MyPerioPath® for periodontal disease bacterial detection and OraRisk HPV® for oral cancer risk screening, supported by the combined Alert 2™ platform. Additional products include OraRisk Caries (cavity risk), Celsus One™ (infectious disease multiplex), MyPerioID IL-6 (inflammatory marker), OraRisk Candida, and OraRisk HSV. All tests use a universal oral rinse collection kit requiring a 30-second swish-and-gargle. The company recently acquired Sensible Diagnostics' patent-pending real-time quantitative PCR platform to expand point-of-care capabilities. Post-therapy monitoring is supported via MyPerioProgress® retesting.

Differentiator

Problem solved

Functional benefit

Products and services

• MyPerioPath Salivary diagnostic test that provides early warning and detection of periodontal disease by identifying specific bacterial pathogens associated with gum disease. Designed for dental providers to support evidence-based treatment planning.
• Alert 2 Combined testing platform integrating MyPerioPath and MyPerioID IL-6 to deliver targeted treatment and personalized care based on both bacterial pathogens and host inflammatory response. For dental providers managing periodontal disease.
• MyPerioID IL-6 Test that measures Interleukin-6 (IL-6) levels to assess host inflammatory response in periodontal disease patients. Supports personalized treatment planning based on genetic inflammatory markers.
• OraRisk Caries Salivary test that determines caries risk by identifying bacteria associated with tooth decay. Used by dental providers for preventive care and risk-based treatment planning.
• OraRisk HPV Test that determines increased risk for HPV-related oral cancers by detecting high-risk HPV strains in oral samples. Used by dental and medical providers for oral cancer risk screening.
• Celsus One Comprehensive salivary test providing Multi-Plexer Infectious Disease detection capabilities. Designed for dental and medical providers seeking broad infectious disease screening from a single sample.
• OraRisk Candida Test that identifies Candida species associated with oral fungal infections. Used by dental providers for diagnosis and targeted treatment of oral candidiasis.
• OraRisk HSV Test that detects Herpes Simplex Virus in oral samples. Used by dental providers for diagnosis and management of oral herpes infections.
• Universal Oral Rinse Collection Kit Standardized 30-second swish-and-gargle collection device used for all OralDNA testing, designed for patient-friendly sample collection in dental and medical practices.
• MyPerioProgress Post-therapy retesting service that measures pathogen reduction following periodontal treatment, confirming measurable clinical outcomes for dental providers and patients.

Quantifiable outcome

• 65% bacteria load decrease with MyPerioPath testing and appropriate therapy
• +3 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Partnerships

Two partnerships are on record, tiered core.

• Pacific Dental Services (PDS)coreChannel Partner/ Reseller/ DistributorPacific Dental Services, a major dental support organization with over 1,000 practices, offers OralDNA testing at its supported dental offices. PDS concluded that OralDNA testing improves oral health outcomes and has integrated salivary diagnostics into its comprehensive care model.
• Sensible DiagnosticscoreTechnology or IntegrationOralDNA Labs acquired Sensible Diagnostics' patent-pending real-time quantitative PCR testing platform, expanding their diagnostic technology capabilities for point-of-care and laboratory testing.

Scale indicators1 record

Recent moves6 records

Expansion highlights4 records

Broad incumbents

• Laboratory Corporation of America (LabCorp): Major clinical laboratory operator with deep molecular diagnostics portfolio. Comparable as a reference lab competitor with the scale and payer relationships that could be redeployed into dental salivary testing.
• Patterson Companies: Major dental and animal health product distributor serving North American dental practices. Comparable as a competing channel whose distribution relationships could rival or complement OralDNA's PDS partnership.
• Henry Schein: Largest distributor of dental supplies and equipment to dental practices. Comparable as an alternative channel that could elect to distribute competing diagnostic products to its dental customer base.
• Sonic Healthcare USA: Global clinical laboratory network with substantial molecular diagnostics capability. Could readily add oral pathogen panels serving dental accounts, representing competitive pressure on OralDNA's test menu.
• Quest Diagnostics: One of the largest U.S. clinical reference labs with extensive molecular, infectious disease, and specialty testing infrastructure. Comparable on testing capability and customer overlap with hospitals/physicians; potential entrant into dental salivary diagnostics.

Regional players

• Heartland Dental: Large U.S. dental support organization supporting hundreds of offices. Relevant peer/distribution analog to Pacific Dental Services; represents an alternate DSO channel that OralDNA could target or that a competitor could lock up.

Direct peers

• BakoDx Diagnostics: Specialized oral pathology laboratory serving dental practices with diagnostic testing services. Closely comparable business model to OralDNA as a dentist-focused clinical lab offering molecular and pathology-based test panels.
• PeriRx Diagnostics: Salivary diagnostics company focused on oral cancer and periodontal disease biomarkers. Directly competes with OralDNA in the dental salivary testing niche using similar non-invasive collection and molecular detection.

Emerging players

• Direct Diagnostics: Dental-focused diagnostic laboratory offering salivary and other targeted tests to dental providers. Comparable as a niche emerging player in the same dental salivary diagnostics category.
• Forward Science Technologies: Developer of point-of-care oral screening and diagnostic products, including the OralID oral cancer screening device. Comparable as an adjacent oral-diagnostics competitor focused on the dental chair rather than send-out lab testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UCKJI6wHFJlg99vf6Lc_KdDA
• Facebookfacebook.com/OralDNA
• LinkedInlinkedin.com/company/oraldna
• Instagraminstagram.com/oraldna
• Xx.com/OralDNA

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about OralDNA Labs